This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1991 Jan;83(1):333-5.

doi: 10.1161/01.cir.83.1.333.

Myocardial viability. What does it mean and how do we measure it?

PMID: 1984890
DOI: 10.1161/01.cir.83.1.333

Editorial

Myocardial viability. What does it mean and how do we measure it?

K L Gould. Circulation. 1991 Jan.

. 1991 Jan;83(1):333-5.

doi: 10.1161/01.cir.83.1.333.

Author

PMID: 1984890
DOI: 10.1161/01.cir.83.1.333

No abstract available

PubMed Disclaimer

Comment on

Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Bonow RO, et al. Circulation. 1991 Jan;83(1):26-37. doi: 10.1161/01.cir.83.1.26. Circulation. 1991. PMID: 1984883 Clinical Trial.

Similar articles

Fluorine 18-labeled fluorodeoxyglucose myocardial single-photon emission computed tomography: an alternative for determining myocardial viability.
Sandler MP, Patton JA. Sandler MP, et al. J Nucl Cardiol. 1996 Jul-Aug;3(4):342-9. doi: 10.1016/s1071-3581(96)90095-1. J Nucl Cardiol. 1996. PMID: 8799254 Review.
Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography.
Dilsizian V, Perrone-Filardi P, Arrighi JA, Bacharach SL, Quyyumi AA, Freedman NM, Bonow RO. Dilsizian V, et al. Circulation. 1993 Sep;88(3):941-52. doi: 10.1161/01.cir.88.3.941. Circulation. 1993. PMID: 8353921
Assessment of myocardial viability: where are we?
McKillop JH. McKillop JH. Nucl Med Commun. 1994 Dec;15(12):935-6. doi: 10.1097/00006231-199412000-00001. Nucl Med Commun. 1994. PMID: 7715890 No abstract available.
Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Bonow RO, et al. Circulation. 1991 Jan;83(1):26-37. doi: 10.1161/01.cir.83.1.26. Circulation. 1991. PMID: 1984883 Clinical Trial.
Metabolic imaging using F18-fluorodeoxyglucose to assess myocardial viability.
Bax JJ, Visser FC, van Lingen A, Cornel JH, Fioretti PM, van der Wall EE. Bax JJ, et al. Int J Card Imaging. 1997 Apr;13(2):145-55; discussion 157-60. doi: 10.1023/a:1005744810876. Int J Card Imaging. 1997. PMID: 9110194 Review.

See all similar articles

Cited by

Myocardial viability: what do we need?
Schoeder H, Friedrich M, Topp H. Schoeder H, et al. Eur J Nucl Med. 1993 Sep;20(9):792-803. doi: 10.1007/BF00180911. Eur J Nucl Med. 1993. PMID: 8223775 Review.
Prediction of contractile reserve by cyclic variation of integrated backscatter of the myocardium in patients with chronic left ventricular dysfunction.
Muro T, Ota T, Watanabe H, Teragaki M, Takeuchi K, Yoshikawa J. Muro T, et al. Heart. 2001 Feb;85(2):165-70. doi: 10.1136/heart.85.2.165. Heart. 2001. PMID: 11156666 Free PMC article.
Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease.
Lucignani G, Paolini G, Landoni C, Zuccari M, Paganelli G, Galli L, Di Credico G, Vanoli G, Rossetti C, Mariani MA, et al. Lucignani G, et al. Eur J Nucl Med. 1992;19(10):874-81. doi: 10.1007/BF00168164. Eur J Nucl Med. 1992. PMID: 1451704
Non-invasive assessment of residual viability in post-myocardial infarction patients. Role of nuclear techniques.
Parodi O, Marzullo P, Sambuceti G, Neglia D, Gimelli A, Giorgetti A. Parodi O, et al. Int J Card Imaging. 1993;9 Suppl 1:19-29. doi: 10.1007/BF01143143. Int J Card Imaging. 1993. PMID: 8409540 Review.
Regional concordance and discordance between rest thallium 201 and sestamibi imaging for assessing tissue viability: comparison with postrevascularization functional recovery.
Marzullo P, Sambuceti G, Parodi O, Gimelli A, Picano E, Giorgetti A, L'Abbate A. Marzullo P, et al. J Nucl Cardiol. 1995 Jul-Aug;2(4):309-16. doi: 10.1016/s1071-3581(05)80075-3. J Nucl Cardiol. 1995. PMID: 9420805

See all "Cited by" articles

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.